Dezhan Healthcare Hits Day Low of CNY 3.37 Amid Price Pressure

Dezhan Healthcare Co., Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, experienced a notable decline today, with its stock price dropping by 5.6%. The stock reached an intraday low of CNY 3.37, reflecting ongoing challenges in its financial performance. Over the past month, Dezhan has seen a significant decrease of 12.92%, while its year-to-date performance mirrors this trend with a decline of 12.24%. In comparison, the China Shanghai Composite index has shown a more resilient performance, with a 1-year return of 16.08%. The company's financial metrics indicate a concerning trajectory, with a Return on Capital Employed (ROCE) of just 1.63%, suggesting low profitability relative to its capital. Additionally, Dezhan has reported negative net sales growth of 25.67% and a staggering net profit decline of 256.3% in its latest half-year results. With a market capitalization of CNY 8,591 million, Dezhan Healthcare continues to face significant headwinds, as evidenced by its underperformance against broader market indices over various time frames.